AMD Center
Age-related macular degeneration or AMD is the leading cause of adult blindness in developed countries and affects nearly 1 in 8 adults over the age of 60. AMD is a chronic, progressive disease that attacks the macula, a part of the retina that allows us to see objects located straight ahead of us. The macula is responsible for your central vision, which allows you to do things like recognize faces, read, watch TV, and drive.
AMD Facts
• It is projected that the overall prevalence of the AMD will be 196 million in 2020 and 288 million in 20401.
• As many as 11 million people in the U.S. have clinical AMD; this number is expected to double by 20501.
• Up to 78% of AMD patients have substantial, irreversible vision loss at first treatment, including 37% who are
legally blind in at least one eye2,3.
• Currently, there is no cure for AMD but progression of the disease can be slowed or halted with lifestyle
modifications, protective eyewear, and nutritional supplements. Timely diagnosis is therefore key.
• Wet AMD (choroidal neovascularization or CNV) may be treated with injections, which can slow or halt disease
progression and vision loss, but not reverse it.
• It is projected that the overall prevalence of the AMD will be 196 million in 2020 and 288 million in 20401.
• As many as 11 million people in the U.S. have clinical AMD; this number is expected to double by 20501.
• Up to 78% of AMD patients have substantial, irreversible vision loss at first treatment, including 37% who are
legally blind in at least one eye2,3.
• Currently, there is no cure for AMD but progression of the disease can be slowed or halted with lifestyle
modifications, protective eyewear, and nutritional supplements. Timely diagnosis is therefore key.
• Wet AMD (choroidal neovascularization or CNV) may be treated with injections, which can slow or halt disease
progression and vision loss, but not reverse it.
